Search results
Author(s):
Larry A Allen
,
John S Rumsfeld
Added:
3 years ago
Hospital readmissions contribute significant clinical and economic burden to patients and payers.1 Nearly 20 % of Medicare patients are readmitted to the hospital within 30 days of discharge, with heart failure listed as the most common reason for readmission.2 Based on a more than twofold variation in institutional readmission rates adjusted for patient clinical characteristics,3 preventable…
View more
Author(s):
Neal W White Jr
Added:
3 years ago
Hospital to Home (H2H) is a national quality improvement initiative of the American College of Cardiology (ACC) and the Institute for Healthcare Improvement (IHI). It builds on the success of the ACC Door-to-Balloon Alliance for Quality and the IHI 100K Lives and 5 Million Lives campaigns. The goal of the H2H initiative is to reduce 30-day all-cause readmission rates for patients discharged with…
View more
Author(s):
Jaime A Hernandez-Montfort
,
Diana Miranda
,
Varinder Kaur Randhawa
,
et al
Added:
2 years ago
SGLT2i Updates 2021
Video Series
Author(s):
Harriette Van Spall
,
James L Januzzi
Added:
10 months ago
ESC-HFA 2023 – Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) joined by Dr James Januzzi (Massachusetts General Hospital, US) to discuss late-breaking science highlights of this year's ESC Heart Failure.
Trials covered in details include:
1:13: First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy
1:42: TRACER-HF:Trientine-HCL for treatment of…
View more
Author(s):
Joseph P Drozda Jr
Added:
3 years ago
Since its foundation six decades ago, the goal of the American College of Cardiology (ACC) has been to improve the quality of cardiovascular care. The College’s founders initially sought to accomplish this goal by providing the College’s members with access to high-quality educational opportunities such as the ACC’s highly successful annual scientific sessions. In 1984, the quest for improved…
View more
Author(s):
Rebecca L Attridge
,
Rebecca D Moote
,
Deborah J Levine
Added:
3 years ago
Pulmonary hypertension is classified into five groups by the World Health Organization (WHO). Group 1, pulmonary arterial hypertension (PAH), is a progressive disease characterized by an elevation in pulmonary arterial pressure and pulmonary vascular resistance that may progress to right heart dysfunction and failure.1 PAH is defined as a mean pulmonary artery pressure (mPAP) ≥25 mmHg at rest,…
View more
Author(s):
Harriette Van Spall
,
Robert Mentz
Added:
1 year ago
AHA 22 - Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) sits down with PI, Dr Robert J Mentz (Duke University of Medicine, US) to discuss the findings of the TRANSFORM-HF trial (NCT03296813).
This study aimed to compare the loop diuretics furosemide and torsemide in the treatment of patients with heart failure.Over 2800 patients were enrolled in the trial and were randomized…
View more
Author(s):
Hilary Shapiro
,
Nosheen Reza
Added:
2 years ago
Author(s):
Clyde W Yancy
Added:
3 years ago
The US population is characterized by significant racial/ethnic demographic transitions with an emerging number of special populations at risk for cardiovascular disease. Amongst the special populations with heart disease, it is heart failure in African-Americans that has become the prototypical model.
Heart FailureÔÇöAn Enigmatic Disease in African-Americans
Chronic heart failure is no longer…
View more